HEIDI ALEXANDRA LANE,FELIX BACHMANN,MADLAINA BREULEUX,MICHAEL BOUTROS,DANIEL GILBERT,XIAN ZHANG
申请号：
PT12701341
公开号：
PT2666016T
申请日:
2012.01.19
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
Use of BUBR1 as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject, wherein the compound is a furazanobenzimidazole compound of general formula (I).
